Healthpeak Properties, Inc. (DOC)
(Delayed Data from NYSE)
$21.98 USD
-0.47 (-2.09%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $22.11 +0.13 (0.59%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Price, Consensus and EPS Surprise
DOC 21.98 -0.47(-2.09%)
Will DOC be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for DOC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DOC
Ventas' Q3 FFO Meet Estimates on Higher Same-Store NOI, View Raised
Medical Properties Stock Down 3% in 3 Months: Time to Buy or Red Flag?
DOC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Welltower's Q3 FFO Beats Estimates, Same-Store NOI Rises Y/Y
Healthpeak's Q3 FFO Beats Estimates, Same-Store NOI Rises
Healthpeak (DOC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for DOC
MOBs, Office But No Need For Life Support
Healthpeak Properties price target raised to $25 from $24 at Baird
Healthpeak Properties price target raised by $1 at Baird, here's why
Doctor Care Anywhere’s Financial Progress and Growth Strategy
KeyBanc Sticks to Its Hold Rating for Healthpeak Properties (DOC)